Shalini Sharp
2016 - Ultragenyx Pharmaceutical
In 2016, Shalini Sharp earned a total compensation of $2M as Chief Financial Officer and Executive Vice President at Ultragenyx Pharmaceutical, a 17% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $185,220 |
|---|---|
| Option Awards | $1,025,693 |
| Salary | $441,000 |
| Stock Awards | $282,280 |
| Other | $32,218 |
| Total | $1,966,411 |
Sharp received $1M in option awards, accounting for 52% of the total pay in 2016.
Sharp also received $185.2K in non-equity incentive plan, $441K in salary, $282.3K in stock awards and $32.2K in other compensation.
Rankings
In 2016, Shalini Sharp's compensation ranked 4,963rd out of 14,075 executives tracked by ExecPay. In other words, Sharp earned more than 64.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,963 out of 14,075 | 65th |
Division Manufacturing | 1,775 out of 5,489 | 68th |
Major group Chemicals And Allied Products | 562 out of 1,895 | 70th |
Industry group Drugs | 418 out of 1,538 | 73rd |
Industry Pharmaceutical Preparations | 333 out of 1,176 | 72nd |
Source: SEC filing on April 28, 2017.
Sharp's colleagues
We found five more compensation records of executives who worked with Shalini Sharp at Ultragenyx Pharmaceutical in 2016.
2016
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
2016
Karah Parschauer
Ultragenyx Pharmaceutical
General Counsel
2016
Jayson Dallas
Ultragenyx Pharmaceutical
Chief Commercial Officer and Executive Vice President
2016
John Pinion
Ultragenyx Pharmaceutical
Chief Quality Operations Officer and Executive Vice President Analytical Sciences and Research
2016
Thomas Kassberg
Ultragenyx Pharmaceutical